Hyperpolarized 129Xe MRI of Survivors of COVID-19
NCT04659707
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Hyperpolarized Xe129
Sponsor
University of Kansas Medical Center